Novaplex HPV28 detection kit purchase

Ended Purchase Order Awarded

Contract number
75D30124P19293
Awardee
Awarding agency
Obligated
$57,490

Award facts

Opportunity
  • 75D30124Q77929 Solicitation number
Contract value 100% obligated
$57,490.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Irvine, CA 92618, USA

Award details come from SAM.gov/FPDS.

About this award

The Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $57,490.00 firm fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, for-profit small disadvantaged business, for the procurement of NOVAPLEX HPV28 DETECTION KITS. The award has an ultimate completion date of May 30, 2025 and supports the CDC's public health mission related to HPV screening and prevention. This order follows previous contract awards to Seegene USA Inc. Sales Division for the supply of HPV test kits, reagents, and associated lab equipment for the CDC's Pittsburgh location. No set-aside program was used for this award.

Quick answers

Who was awarded contract 75D30124P19293?

75D30124P19293 was awarded to Seegene Usa, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 8, 2024.

How much is contract 75D30124P19293 worth?

The government has obligated $57,490 on 75D30124P19293.

Was contract 75D30124P19293 competed?

The extent of competition for 75D30124P19293 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award